Sign in
Taking people in United StatesNo phase

Worldwide registry of heart problems linked to cancer treatment

Collects health data to find risk factors for heart harm in cancer patients.

Key facts

Who runs it
The Cleveland Clinic
Where
Weston, United StatesSee the site
Trial code
Registry title
Global Cardio Oncology Registry
Status
Recruiting
People taking part
5,000 people, planned
Started
1 Jul 2022
Expected to end
1 Jul 2029
Type of study
Observational, 3 groups
Treatments tested
  • anonymized data collection during programmed surveillance clinical follow up
Record updated
12 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with breast cancer, blood cancers, or cancer treated with immune checkpoint inhibitors who have a first visit with a heart-and-cancer (cardio-oncology) doctor. It only collects data during usual check-ups.

Age
18 years or older
Sex
All sexes
Disease stage
Breast cancer, Hodgkin's or non-Hodgkin's lymphoma, acute or chronic leukemia, multiple myeloma or AL amyloidosis, or any cancer treated with immune checkpoint inhibitors that needs a heart check.
Earlier treatment
For one group: treatment with immune checkpoint inhibitors.

Main reasons for not taking part

  • People who already had a cardio-oncology check and follow-up by the trial doctors
  • People younger than 18 years
  • People unable or unwilling to give consent

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • New cardio-oncology consultation for breast cancer patients, or
  • New cardio-oncology consultation for Hodgkin's or non-Hodgkin's lymphoma patients, or
  • New cardio-oncology consultation for acute or chronic leukemia patients, or
  • New cardio-oncology consultation for multiple myeloma or AL amyloidosis, or
  • New cardio-oncology consultations for immune check-point inhibitors cardiac evaluation
  • All patients have to be 18 years old or older

Who cannot take part

  • Cardio-oncology patients who have previously had cardio-oncology evaluation and follow up by the investigators
  • Minors less than 18 years old
  • Inability or unwillingness to consent to participate

Where in United States

  • Cleveland Clinic FloridaWeston, United StatesContact: Diego Sadler, MD FACCTaking people

About the trial

What the trial wants to find out

G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.

The 3 groups in the trial

  • Breast cancer

    Patients with breast cancer who present for initial cardio-oncology consultation. Clinical follow up for 18 months.

    Treatment: anonymized data collection during programmed surveillance clinical follow up

  • Hematological malignancies

    Patients with lymphomas, leukemias, multiple myeloma, and AL amyloidosis who present for initial cardio-oncology consultation. Clinical follow up for 18 months.

    Treatment: anonymized data collection during programmed surveillance clinical follow up

  • Immune check point inhibitors

    Patients with any type of cancer treated with immune check point inhibitors who present for initial cardio-oncology consultation. Clinical follow for 18 months

    Treatment: anonymized data collection during programmed surveillance clinical follow up

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Global Cardio Oncology Registry
Plain-language title
Worldwide registry of heart problems linked to cancer treatmentGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
12 May 2026